- Q1 2024 Procept Biorobotics Corp Earnings Call TranscriptMay 01, 2024$60.61 (+14.40%)Earnings
- Q4 2023 Procept Biorobotics Corp Earnings Call TranscriptFeb 27, 2024$50.75 (+3.91%)Earnings
- Q3 2023 PROCEPT BioRobotics Corp Earnings Call TranscriptNov 01, 2023$27.55 (+2.84%)Earnings
- Q2 2023 PROCEPT BioRobotics Corp Earnings Call TranscriptJul 27, 2023$35.14 (-7.14%)Earnings
- PROCEPT BioRobotics Corp at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 PROCEPT BioRobotics Corp Earnings Call TranscriptApr 27, 2023$26.7 (-25.31%)Earnings
- Q4 2022 PROCEPT BioRobotics Corp Earnings Call TranscriptFeb 28, 2023$37.45 (+0.24%)Earnings
- PROCEPT BioRobotics Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Procept Biorobotics Corp Earnings Call TranscriptNov 03, 2022$44 (-0.48%)Earnings
- Q2 2022 Procept Biorobotics Corp Earnings Call TranscriptAug 04, 2022$38.37 (-4.77%)Earnings
- Procept Biorobotics Corp At The American Urology Association Annual Meeting Call TranscriptMay 13, 2022
- Procept Biorobotics Corp at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Procept Biorobotics Corp Earnings Call TranscriptMay 05, 2022$35.13 (-5.59%)Earnings
- Q4 2021 Procept Biorobotics Corp Earnings Call TranscriptMar 08, 2022$24.99 (+6.20%)Earnings
- Q3 2021 Procept Biorobotics Corp Earnings Call TranscriptNov 04, 2021$43.97 (-2.25%)Earnings
Q1 2022 Procept Biorobotics Corp Earnings Call Transcript
Thanks, operator. Good afternoon, and thank you for participating in today's call. Joining me from PROCEPT BioRobotics are Reza Zadno, CEO; and Kevin Waters, CFO. Earlier today, PROCEPT released financial results for the quarter ended March 31, 2022. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.
All forward-looking statements, including, without limitation, those related to our sales and operating trends and future financial performance, expense management expectations for hiring or growth, market opportunity, revenue guidance, commercial expansion, the impact of COVID-19 on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)